Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethical issues in schizophrenia research: a commentary on some current concerns.

David Shore1

  • 1Office of the Director, NIMH, 6001 Executive Blvd., 8221, Bethesda, MD 20892, USA. DShore@mail.nih.gov

Schizophrenia Bulletin
|December 2, 2005
PubMed
Summary

Protecting vulnerable individuals in schizophrenia research requires ethical oversight and informed consent. Key issues include medication discontinuation, placebo controls, compensation, and capacity to consent, necessitating further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A two-step regulatory mechanism dynamically controls histone H3 acetylation by SAGA complex at growth-related promoters.

Nucleic acids research·2025
Same author

K29-linked free polyubiquitin chains affect ribosome biogenesis and direct ribosomal proteins to the intranuclear quality control compartment.

Molecular cell·2024
Same author

K29-linked unanchored polyubiquitin chains disrupt ribosome biogenesis and direct ribosomal proteins to the Intranuclear Quality control compartment (INQ).

bioRxiv : the preprint server for biology·2023
Same author

Not1 and Not4 inversely determine mRNA solubility that sets the dynamics of co-translational events.

Genome biology·2023
Same author

GPR68 limits the severity of chemical-induced oral epithelial dysplasia.

Scientific reports·2023
Same author

Pitfalls in using phenanthroline to study the causal relationship between promoter nucleosome acetylation and transcription.

Nature communications·2022

Area of Science:

  • Psychiatry
  • Clinical Research Ethics
  • Neuroscience

Background:

  • Ethical conduct in schizophrenia research is crucial to protect vulnerable populations.
  • Federal regulations (45 CFR 46.111a3) emphasize special considerations for individuals with mental disabilities.
  • Recent advancements focus on enhanced subject monitoring and evolving informed consent processes.

Purpose of the Study:

  • To highlight current ethical challenges in schizophrenia research.
  • To underscore the need for empirical study on specific controversial issues.
  • To promote ethical awareness among researchers, participants, and oversight bodies.

Main Methods:

  • Review of ethical principles and federal regulations pertinent to schizophrenia research.
  • Identification of current controversial issues requiring further investigation.

Related Experiment Videos

  • Focus on key areas including medication discontinuation, placebo controls, compensation, and capacity to consent.

    • Main Results:

    • Schizophrenia research necessitates stringent ethical guidelines to prevent unreasonable risk to participants.
    • Informed consent processes are evolving to ensure participant comprehension of study details.
    • Specific issues like medication discontinuation, placebo use, participant compensation, and consent capacity require further empirical examination.

    Conclusions:

    • Ethical considerations are paramount in schizophrenia research to safeguard participant welfare.
    • Continuous evolution of ethical practices, including informed consent and subject monitoring, is essential.
    • Further empirical research is vital to address complex ethical dilemmas in schizophrenia studies.